Updated April 12, 2026Expert Reviewed

Best Semaglutide 2.4mg Providers — Ranked & Reviewed

The 2.4mg max dose is one of the most-searched semaglutide tiers. We compare every telehealth provider that offers compounded or brand-name semaglutide at this dose, ranked by independent score, monthly price, and patient reviews.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Methodology & sources

Providers in this variant are scored against our published six-factor rubric[1], then filtered to match the specific dose shown in the page title.

Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[2]. The SURMOUNT-5 head-to-head published in 2025 directly compared tirzepatide and semaglutide[3].

No providers match this variant yet. Check back soon — pricing data is being backfilled.
← See all Semaglutide Providers

Frequently Asked Questions

Sources & methodology — as of April 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  3. 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.